FBLG FBLG
Company Profile ↓Company Overview
FBLG (FBLG) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Growth & Price Performance
Stock Price Performance
| 1 Year: | -92.87% |
| 6 Months: | -84.33% |
| 3 Months: | -34.74% |
| 1 Month: | +3.33% |
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)56.37 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading 93.0% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income | -2.27M | -2.09M | -2.05M | -3.45M | -3.22M | -3.35M | -4.53M | -4.49M | -5.04M | -5.07M | -4.03M |
| Net Income | -2.42M | -2.16M | -2.19M | -8.46M | 898.00K | -500.00K | -4.97M | -4.66M | -5.78M | -5.00M | -4.12M |
| Diluted EPS | -0.18 | -0.08 | -0.08 | -0.27 | 0.03 | -0.01 | -2.71 | -2.41 | -0.13 | -1.33 | -0.66 |
| R&D Expense | 478.00K | 547.00K | 571.00K | 960.00K | 975.00K | 1.21M | 1.78M | 2.04M | 2.79M | 2.95M | 1.66M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Operating Income | -4.47M | -8.89M | -13.74M | -16.65M |
| Net Income | -5.12M | -16.48M | -11.16M | -18.65M |
| Diluted EPS | -0.18 | -0.68 | -0.34 | -0.42 |
| R&D Expense | 1.15M | 2.37M | 4.50M | 7.41M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 4.82M | 11.82M | 16.45M | 9.62M |
| Total Equity | -1.29M | -4.00M | 1.25M | 2.73M | 6.16M |
| Cash & Equivalents | - | 2.27M | 9.16M | 13.98M | 4.89M |
| Total Liabilities | - | 8.82M | 10.57M | 13.71M | 3.46M |
| Current Liabilities | - | 7.07M | 9.18M | 12.73M | 1.76M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Operating Cash Flow | -4.07M | -6.40M | -11.90M | -16.39M |
| Investing Cash Flow | - | -495.00K | -184.00K | -262.00K |
| Financing Cash Flow | 5.92M | 13.79M | 16.91M | 7.57M |
| Capital Expenditure | - | -495.00K | -184.00K | -262.00K |
| Free Cash Flow | - | -6.90M | -12.09M | -16.66M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Gross Margin % | - | - | - | - |
| Operating Margin % | - | - | - | - |
| Net Margin % | - | - | - | - |
| ROE % | 128.2% | -1,315.6% | -408.1% | -302.9% |
| ROCE % | 198.6% | -337.0% | -369.4% | -211.8% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for FBLG
FibroBiologics patent covers Sox9 turning fibroblasts into cartilage cells - Stock Titan
<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxQOERkYkVHd05QUHRnS05SeFltZFBlOHl2cmdkS1FxVEhYajlSNTNtSDJtcGNjNEhTZ0xxN0VxWFBIeFY5eVBSRGR6dFotY2NYcG9wbFpQVlJoaEJqeDdUam5TaWc3UDgyVlQ4eGpHMTRnU2RyZjNxRHJLV2l3TktXb1ZuNnRWU2FsN1hRbV…
FIBROBIOLOGICS ($FBLG) Releases Q2 2026 Earnings - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxObTZ4c3lyQ0NYVVFPQjNvOGxUUFFPYWpDUVBpTWV6WXpZOXpvRWgyZVVDREVzb3dNbE9lVlRxY2N6S3lLc2I2VVljRmZWeGJlTFBnYkZNMllyVEdkN3NTc0hmZ3B2amlDYVlGSGt3TmdrZGJITlNyNm1rTnV3R1dGRnFmZzNXNUJ5Vkh4TF…
FibroBiologics, Inc. Revenue Breakdown – NASDAQ:FBLG - TradingView
<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTE55OXE5SzlkRmh6dUhHTDJMNFdGMk1zR2plcndTQ2IxS2RWVEh3ZnJ0UWtlSS0yTlFsM2FlMk0xa3l4ME1JMmpRVndFSkdOdVlPY29abDM0YTFkemFrb1F0VTZkMzlsYWdLeEh4Z0JmWGNYS1d1WEVn?oc=5" target="_blank">FibroBi…
FibroBiologics Starts Human Testing for Diabetic Foot Ulcers - Stock Titan
<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxPTDZrVURzNC12TjVsUF84ZmdNS3dDQ2prdkZRTFlxWlhZUHNyN21aWHEwUG8zRkNFVURtMy1EZ0RaOHJlSzVIOEhNbTNMRnJIV1pNSFBST01PSFUtcXJUWDQ2R1VpZzhMSzVtOWs2cW9kWkFONU9fSVgtd1drZVBQbG4yeWFmSmxISUxKUE…
FibroBiologics Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Bid Price Requirement - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxObWp3R3NzVnU4VUVEUURaa3lybE92WjRxTUlaRGVPbWE3QUxyUWsxZ1MwOXBJeHdSMDJKS0VlaWI4WVp4eFNSdU5RaUM3RTZvWU03a1VfMmo1VE94ajJRRkc0c3UyWmQzdGV1d3lJd01HRDhLQ3EyS092dk5ydTIzZEdteVRRbHFkazZJV3…
FibroBiologics Announces up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules - PR Newswire
<a href="https://news.google.com/rss/articles/CBMi7AFBVV95cUxPOXFpbGcyTTVYT1plRVl2QU9McXNLaFhTVnRPM0U3RHV3TUFjeS1SNlR6MUVsTnVSd3l0MGpCVnJMclR2YzRfOXpBQ01Bb2RBYVl4RGlyT1dGZlYzcTFDMzlmM0N5SXI4bTBGb2VrTkVoTFd6U2J6SFlQa1dsOTVydzlIOExDeDFFRTZ0VW…
FBLG — Frequently Asked Questions
What is the current share price of FBLG?
As of 2026-08-05 17:25 PDT, FBLG trades at $0.87 on NASDAQ/NYSE. Its 52-week range is $0.63 to $12.42.
What is the P/E ratio of FBLG?
FBLG trades at a trailing price-to-earnings (P/E) ratio of -2.07.
Is FBLG a good stock to buy?
This page provides a data-driven analysis of FBLG, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.